Is the extension of adjuvant hormone therapy for breast cancer justified? by V. F. Semiglazov, V. S. Apollonova

Get full text

Adjuvant therapy in premenopausal women with hormone-dependent breast cancer by V. F. Semiglazov, V. Yu. Lifanova, V. S. Appolonova

Get full text

CHEMOTHERAPY BREAST CANCER MODERN VIEW ON THE PROBLEM by V. F. SEMIGLAZOV, V. A. GORBUNOVA, S. A. TYULYANDIN

Get full text

Male breast cancer: review of the literature by K S Nikolaev, V F Semiglazov, V V Semiglazov

Get full text

General recommendations for the management of breast cancer (St. Gallen Expert Consensus developed at the 16^thth International Breast Cancer Conference) by V. F. Semiglazov, R. M. Paltuev, V. V. Semiglazov

Get full text

ADJUVANT HORMONE THERAPY ELIGIBILITY OF PREMENOPAUSAL WOMEN WITH ER+ BREAST CANCER by V. F. SEMIGLAZOV, V. V. SEMIGLAZOV, V. Y. LIFANOVA

Get full text

Predoperatsionnaya (neoad\"yuvantnaya) endokrinoterapiya postmenopauzal'nykh bol'nykh rakom molochnoy zhelezy by V F Semiglazov, V V Semiglazov, E K Zhil'tsova

Get full text

Genotype-phenotype correlations in patients with breast cancer and BRCA1 mutations (4153delA, 185delAG, 5382insC) by Ye. M. Bit-Sava, V. F. Semiglazov, Ye. N. Imyanitov

Get full text

Adjuvant endocrinotherapy of postmenopausal patients with breast cancer by V. F. Semiglazov, A. A. Malodusheva, V. G. Ivanov, P. V. Krivorotko

Get full text

AUTOMATED ANALYSIS OF CELL DENSITY IN BREAST CANCER AS AN ADDITIONAL METHOD OF INCREASING OBJECTIVITY AND ACCURACY OF BREAST CANCER PROGNOSIS by R. M. Paltuev, A. G. Kudabergenova, V. F. Semiglazov, A. V. Komyakhov

Get full text

The main markers of the long-term efficiency of neoadjuvant chemotherapy in breast cancer (review of literature) by V F Semiglazov, V V Semiglazov, P M Paltuev, K S Nikolaev, G A Dashyan

Get full text

Quality of life is an important criterion for the efficiency of targeted therapy for metastatic skeletal involvement in breast cancer by T. Yu. Semiglazova, V. V. Semiglazov, L. V. Filatova, P. V. Krivorotko, V. V. Kolarkova, V. F. Semiglazov

Get full text

Znachenie taksanov v neoad\"yuvantnoy terapii raka molochnoy zhelezy by A A Bozhok, V F Semiglazov, A E Kletsel', A S Arzumanov, O A Ivanova, V V Semiglazov

Get full text

General St. Gallen-2015 guidelines for the treatment of early breast cancer (adapted by the experts of the Russian Society of Breast Oncologists) by V. F. Semiglazov, R. M. Paltuev, V. V. Semiglazov, G. A. Dashyan, T. Yu. Semiglazova, P. V. Krivorotko, K. S. Nikolaev

Get full text

Future prospects for breast cancer immunotherapy by V. F. Semiglazov, A. I. Tseluiko, R. V. Donskikh, P. V. Krivorotko, G. A. Dashyan, V. V. Semiglazov, A. V. Komyakhov

Get full text

Breast cancer biomarker (ER, PR, HER2) changes in the phenotype after neoadjuvant treatment by V. O. Bashlyk, A. G. Kudaibergenova, A. S. Artemyeva, A. L. Muravtseva, V. S. Chirsky, T. Yu. Semiglazova, V. V. Klimenko, V. F. Semiglazov

Get full text

Post-neoadjuvant treatment of breast cancer by V. F. Semiglazov, M. A. Dzhelialova, S. S. Yerechshenko, E. T. Munaeva, R. S. Pesotsky, A. I. Tseluyko, A. S. Emelyanov, R. V. Donskikh, P. V. Krivorotko

Get full text

Novoe v terapii raka molochnoy zhelezy: neoad\"yuvantnaya gormonoterapiya by V F Semiglazov, V V Semiglazov, V G Ivanov, L M Bershteyn, E V Tsyrlina, E K Zhil'tsova, A S Arzumanov, K Sh Nurgaziev

Get full text

Quality of life is the fundamental criterion of the efficacy of targeted therapy in patients with metastatic Her2-positive breast cancer by T Yu Semiglazova, G A Dashyan, V V Semiglazov, A S Zhabina, M A Osipov, Z S Kotova, V V Klimenko, P V Krivorotko, V F Semiglazov

Get full text

The role of digital mammography, scintimammography with ^99mTc-methoxyisobutylisonitrile (MIBI) and ultrasound in the diagnosis of multicentric breast cancer by A. V. Chernaya, P. I. Krzhivitskiy, E. A. Busko, P. V. Krivorotko, A. S. Artemyeva, N. S. Popova, V. V. Danilov, V. F. Semiglazov, S. N. Novikov, S. V. Kanaev

Get full text